431 participants were given either 3 g ALCAR daily for a year or a placebo daily for a year and were measured with two cognitive performance scales
Przybysz JT, et al
Frequently Asked Questions What is the MTHFR mutation
Most patients begin experiencing noticeable appetite suppression within one to four weeks of starting semaglutide, a GLP-1 receptor agonist FDA-approved for chronic weight management and type 2 diabetes
Importantly, this effect often attenuates over time with long-acting agents (tachyphylaxis), though the weight loss and glycemic benefits typically persist
Topical GHK-Cu is primarily used for: Anti-aging skincare (wrinkle reduction, skin tightening, complexion improvement) Post-procedure skin recovery (after microneedling, laser treatments, chemical peels) Hair restoration (applied to scalp) Wound care and scar reduction This patient population is broad, ranging from aesthetic medicine patients to individuals managing chronic wounds
